This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/can-restoring-ocular-perfusion-restore-vision-oct-a-and-vascular-therapies

Test your visual field online: https://visualfieldtest.com

Excerpt:

Can Restoring Ocular Perfusion Restore Vision? OCT-A and Vascular TherapiesGlaucoma is a disease where the optic nerve gradually loses nerve fibers, leading to vision loss. In most cases, lowering eye pressure (intraocular pressure or IOP) is the proven way to slow or stop progression. However, researchers have long wondered whether improving blood flow to the eye (ocular perfusion) could also help preserve or even restore vision. New imaging tools like optical coherence tomography angiography (OCT-A) can noninvasively measure tiny blood vessels in the optic nerve head and retina. This article reviews what is known about OCT-A vascular measurements and visual function in glaucoma, and whether treatments aimed at enhancing perfusion (such as Rho-kinase inhibitors or blood pressure adjustments) might recover vision. We will also consider how future studies could tease apart the effects of blood flow versus pressure, and suggest OCT-A–based endpoints to predict if vision recovery is possible. Vascular Metrics and Visual Function in GlaucomaOCT-Angiography and Vessel DensityOCT-Angiography (OCT-A) captures images of blood flow by detecting moving red blood cells in the eye’s capillaries. Two key metrics are often reported: vessel density (the percentage area occupied by vessels) and flow index. In glaucoma, multiple studies have found that eyes with glaucoma have lower OCT-A vessel density than healthy eyes. For example, a large study showed that normal eyes had significantly higher peripapillary (around the optic nerve) vessel density than glaucoma eyes. In that study, average vessel density in healthy eyes was about 55%, versus 42% in advanced glaucoma eyes (). Notably, this vessel density loss closely matched the degree of visual field loss: each 1% drop in vessel density corresponded to about a 0.6 dB worsening in visual field mean deviation (). In fact, the association between vessel density and vision loss was stronger than the association between traditional structural measurements (like nerve fiber thickness) and vision (). Macular vessel density (in the central retina) has also been linked to vision in glaucoma. A study of glaucoma patients found that lower macular capillary density was associated with poorer central visual sensitivity on a 10-2 visual field test (). In advanced glaucoma, larger areas of the foveal avascular zone (FAZ) – meaning more loss of central capillaries – were linked to worse visual acuity (clarity of vision) (). In moderate glaucoma, eyes with lower macular vessel density had worse distance vision. In short, reduced blood flow metrics on OCT-A – both around the optic nerve and in the macula – tend to go hand-in-hand with worse visual function () () ().Why might blood flow measures reflect vision? One idea is that reduced capillary perfusion may indicate that nerves are starved of oxygen and nutrients. Lower perfusion might occur even before nerve fibers are fully lost, so OCT-A could detect early dysfunction. In fact, experts note that a reduction in capillary perfusion is a sign of vascular dysfunction and might precede permanent nerve fiber loss (). Thus, OCT-A vessel density can serve as an early warning, potentially showing damage in not-yet-destroyed nerve fibers (). This suggests that vascular changes measured by OCT-A do relate to functional outcomes in glaucoma, even though they are not part of routine te

Support the show